HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piotr Wlaź Selected Research

Orphenadrine (Disipal)

6/2014Orphenadrine-induced convulsive status epilepticus in rats responds to the NMDA antagonist dizocilpine.
4/2011Orphenadrine induces secondarily generalized convulsive status epilepticus in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piotr Wlaź Research Topics

Disease

27Seizures (Absence Seizure)
01/2022 - 04/2003
21Epilepsy (Aura)
01/2022 - 03/2010
5Erectile Dysfunction
10/2018 - 09/2009
5Mental Disorders (Mental Disorder)
04/2016 - 10/2014
4Mood Disorders (Mood Disorder)
01/2020 - 06/2012
3Inflammation (Inflammations)
12/2021 - 02/2010
3Status Epilepticus (Complex Partial Status Epilepticus)
06/2014 - 02/2010
2Pain (Aches)
12/2021 - 01/2019
2Neuralgia (Stump Neuralgia)
12/2021 - 01/2019
2Overactive Urinary Bladder (Overactive Bladder)
01/2019 - 01/2019
2Asthma (Bronchial Asthma)
01/2016 - 01/2013
2Depressive Disorder (Melancholia)
10/2013 - 01/2013
2Hypersensitivity (Allergy)
01/2013 - 02/2010
1Weight Gain
11/2021
1Type 2 Diabetes Mellitus (MODY)
12/2020
1Parkinson Disease (Parkinson's Disease)
12/2020
1Obesity
12/2020
1Stroke (Strokes)
12/2020
1Cardiovascular Diseases (Cardiovascular Disease)
12/2020
1Neoplasms (Cancer)
12/2020
1Dementia (Dementias)
12/2020
1Alzheimer Disease (Alzheimer's Disease)
12/2020
1COVID-19
11/2020
1Nervous System Diseases (Neurological Disorders)
03/2020
1Blister (Bulla)
01/2019
1Anxiety Disorders (Anxiety Disorder)
01/2018
1Urge Urinary Incontinence (Urge Incontinence)
10/2017
1Hemorrhagic Cystitis
06/2017
1Cystitis
06/2017
1Edema (Dropsy)
06/2017
1Pulmonary Arterial Hypertension
04/2017
1Hypothermia
01/2017

Drug/Important Bio-Agent (IBA)

21Anticonvulsants (Antiepileptic Drugs)IBA
12/2021 - 04/2003
8Pentylenetetrazole (Metrazol)IBA
01/2022 - 03/2010
8Sildenafil Citrate (Viagra)FDA Link
11/2018 - 09/2009
6Pharmaceutical PreparationsIBA
11/2019 - 09/2009
6N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2018 - 04/2003
5Phosphodiesterase 5 InhibitorsIBA
11/2018 - 03/2010
4Antidepressive Agents (Antidepressants)IBA
01/2019 - 10/2013
4GlucocorticoidsIBA
12/2015 - 05/2012
3Itraconazole (Sporanox)FDA LinkGeneric
08/2015 - 01/2013
2MagnesiumIBA
01/2022 - 01/2013
2Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021 - 01/2019
2Formaldehyde (Formol)FDA Link
12/2021 - 01/2019
2Topiramate (Topamax)FDA LinkGeneric
01/2021 - 02/2010
2ZincIBA
11/2020 - 01/2019
2blebbistatinIBA
01/2019 - 01/2019
2N-Methylaspartate (NMDA)IBA
11/2018 - 06/2014
2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
04/2017 - 10/2012
2Caffeine (No Doz)FDA LinkGeneric
02/2016 - 09/2015
2Orphenadrine (Disipal)FDA LinkGeneric
06/2014 - 04/2011
2Dizocilpine Maleate (Dizocilpine)IBA
06/2014 - 11/2010
2ConvulsantsIBA
10/2012 - 09/2009
2Sarcosine (Methylglycine)IBA
01/2011 - 03/2010
1Capsaicin (Zostrix)FDA Link
12/2021
1CarrageenanIBA
12/2021
1Propofol (Diprivan)FDA LinkGeneric
11/2021
1Hypnotics and Sedatives (Sedatives)IBA
11/2021
1Anesthetics (Anesthetic Agents)IBA
11/2021
1Sevoflurane (Ultane)FDA LinkGeneric
11/2021
1pterostilbeneIBA
11/2021
1Lamotrigine (Lamictal)FDA LinkGeneric
01/2021
1Felbamate (Felbatol)FDA Link
01/2021
1Levetiracetam (Keppra)FDA LinkGeneric
01/2021
1CoffeeFDA Link
12/2020
1ElementsIBA
11/2020
1salvinorin AIBA
03/2020
1Opioid Receptors (Opioid Receptor)IBA
03/2020
1CannabinoidsIBA
01/2020
1Valproic Acid (Depakote)FDA LinkGeneric
01/2020
1CannabidiolIBA
11/2019
1Biological ProductsIBA
01/2019
1retinol acetateIBA
01/2019
1Myosin Type IIIBA
01/2019
1Flumazenil (Romazicon)FDA LinkGeneric
11/2018
12-amino-4-methyl-5-phosphono-3-pentenoic acidIBA
11/2018
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
11/2018
11,3-dipropyl-8-cyclopentylxanthineIBA
11/2018
1Glutamate Receptors (Glutamate Receptor)IBA
11/2018
1Serotonin AntagonistsIBA
11/2018
1Adenosine A1 ReceptorIBA
11/2018
1Narcotic Antagonists (Opioid Antagonists)IBA
11/2018
1Diazepam (Valium)FDA LinkGeneric
11/2018
1MetergolineIBA
11/2018
1GABA-A Receptors (GABA(A) Receptor)IBA
11/2018
1Tadalafil (Cialis)FDA Link
10/2018
1BenzodiazepinesIBA
01/2018
1Alprazolam (Xanax)FDA LinkGeneric
01/2018
1Purinergic P2X7 ReceptorsIBA
11/2017
1SN003IBA
10/2017
1Imipramine (Janimine)FDA LinkGeneric
10/2017
1rho-Associated KinasesIBA
06/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2017
1Coloring Agents (Dyes)IBA
06/2017
1Evans Blue (Blue, Evans)FDA Link
06/2017
1sulforaphaneIBA
01/2017
1TRPV1 receptorIBA
04/2016
1OrexinsIBA
04/2016

Therapy/Procedure

2Therapeutics
11/2019 - 01/2013
2Drug Therapy (Chemotherapy)
01/2019 - 10/2014